VHI VALHI INC /DE/
Industrial Inorganic Chemicals · NYSE · SEC CIK 59255 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.0%
TTM net income YoY-92.9%
TTM EPS YoY-93.8%
Revenue 3-yr CAGR6.3%
Net income 3-yr CAGR—
Margins
Gross margin17.8%
Operating margin6.1%
Net margin0.1%
FCF margin5.3%
EBITDA margin9.1%
Returns
ROE0.1%
ROA0.0%
ROIC (approx.)6.8%
Asset turnover0.85x
Leverage & solvency
Liabilities / assets44.6%
Debt / equity0.52x
Current ratio3.29x
Interest coverage2.35x
Cash quality & payout
Operating cash flow / net income132.54x
Accruals ratio-6.5%
Payout ratio700.0%
Capex / revenue2.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $589.00M | $606.10M | $560.10M | $494.50M | $503.50M | $540.40M | $538.60M | $480.90M |
| Cost of revenue | $446.90M | $486.00M | $457.10M | $460.30M | $442.90M | $462.30M | $416.10M | $380.30M |
| Gross profit | $142.10M | $120.10M | $103.00M | $34.20M | $60.60M | $78.10M | $122.50M | $100.60M |
| SG&A expense | $82.00M | $78.80M | $77.50M | $77.00M | $77.60M | $79.20M | $78.50M | $38.50M |
| Operating income | $67.40M | $67.70M | $32.90M | -$30.90M | $8.60M | $35.50M | $50.10M | $56.70M |
| Interest expense | $13.80M | $14.70M | $14.70M | $15.20M | $14.90M | $13.80M | $13.20M | $13.30M |
| Pretax income | $48.80M | $47.30M | $14.10M | -$81.70M | -$7.60M | $15.50M | $30.80M | $68.70M |
| Income tax | $8.00M | $11.80M | $6.30M | -$18.40M | $14.30M | $8.00M | $8.00M | $36.30M |
| Net income | $30.20M | $22.30M | $2.00M | -$53.20M | -$22.20M | $900,000 | $16.90M | $22.80M |
| EBITDA | $84.20M | $84.80M | $49.80M | -$13.50M | $25.70M | $52.00M | $65.50M | $72.20M |
| EPS (basic) | 1.06 | 0.78 | 0.07 | — | -0.78 | 0.03 | 0.59 | — |
| EPS (diluted) | 1.06 | 0.78 | 0.07 | — | -0.78 | 0.03 | 0.59 | — |
| Dividends declared per share | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Weighted avg. shares (diluted) | 28.60M | 28.50M | 28.50M | — | 28.50M | 28.50M | 28.50M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $216.90M | $209.70M | $193.70M | $214.00M | $183.50M | $188.50M | $194.50M | $348.30M |
| Short-term investments | $2.90M | $2.70M | $2.20M | $2.90M | $3.10M | $2.40M | $1.90M | $1.90M |
| Inventory | $515.30M | $530.90M | $580.10M | $659.80M | $690.90M | $717.20M | $729.70M | $685.80M |
| Current assets | $1.23B | $1.22B | $1.25B | $1.26B | $1.34B | $1.37B | $1.41B | $1.45B |
| PP&E, net | $733.60M | $732.40M | $739.00M | $751.60M | $753.80M | $759.80M | $733.80M | $723.40M |
| Goodwill | $382.30M | $382.30M | $382.30M | $382.30M | $382.30M | $382.30M | $382.30M | $382.30M |
| Total assets | $2.58B | $2.57B | $2.61B | $2.63B | $2.72B | $2.76B | $2.76B | $2.80B |
| Current liabilities | $372.10M | $361.20M | $386.00M | $449.30M | $369.00M | $483.10M | $528.60M | $643.80M |
| Short-term debt | $800,000 | $800,000 | $800,000 | $800,000 | $800,000 | $88.70M | $81.90M | $79.00M |
| Long-term debt | $554.70M | $586.70M | $624.50M | $590.90M | $661.50M | $544.80M | $525.90M | $484.40M |
| Total debt | $555.50M | $587.50M | $625.30M | $591.70M | $662.30M | $633.50M | $607.80M | $563.40M |
| Total liabilities | $1.15B | $1.18B | $1.24B | $1.27B | $1.31B | $1.33B | $1.34B | $1.42B |
| Shareholders' equity | $1.07B | $1.04B | $1.03B | $1.02B | $1.05B | $1.07B | $1.06B | $1.04B |
| Net debt | $338.60M | $377.80M | $431.60M | $377.70M | $478.80M | $445.00M | $413.30M | $215.10M |
| Shares outstanding | — | — | — | 29.60M | — | — | — | 29.60M |
| Cash flow statement | ||||||||
| Operating cash flow | $58.70M | $59.10M | -$46.10M | $100.60M | -$1.90M | $21.70M | -$155.90M | $45.80M |
| Capital expenditure | $15.10M | $17.20M | $10.60M | $10.80M | $10.40M | $12.60M | $12.80M | $12.50M |
| Free cash flow | $43.60M | $41.90M | -$56.70M | $89.80M | -$12.30M | $9.10M | -$168.70M | $33.30M |
| Investing cash flow | -$15.50M | -$11.70M | -$9.50M | -$11.00M | -$12.10M | -$12.40M | -$12.30M | -$7.40M |
| Financing cash flow | -$37.00M | -$40.10M | $42.50M | -$85.20M | $14.80M | -$20.60M | $19.90M | -$20.40M |
| Depreciation & amortization | $16.80M | $17.10M | $16.90M | $17.40M | $17.10M | $16.50M | $15.40M | $15.50M |
| Dividends paid | $2.30M | $2.20M | $2.30M | $2.30M | $2.30M | $2.20M | $2.30M | $2.30M |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.